{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:06:54Z","timestamp":1784383614489,"version":"3.55.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Nonalcoholic steatohepatitis (NASH) is a multisystem disease that affects not only the liver but also heart, pancreas, and kidney. We currently lack a comprehensive understanding of mechanisms responsible for the development of NASH-associated cardiomyopathy or the influence of sex on pathophysiology. There is a critical need to address these gaps in knowledge in order to accelerate translation of knowledge into clinical practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>NASH and cardiovascular disease share common risk factors such as chronic inflammation, hyperlipidemia, and insulin resistance. Early cardiac dysfunction in NASH that is independent of obesity or other cardiometabolic risk factors suggests roles for liver\u2013heart crosstalk in disease pathogenesis. Inflammation is a driving force in the pathogenesis of NASH, and it is likely that \u2018spill over\u2019 of NASH inflammation contributes to the development of cardiomyopathy. However, molecular and cellular mechanisms that mediate NASH-associated cardiomyopathy remain unclear because of inherent limitations of experimental models. Even so, recent studies implicate inflammatory, metabolic, and physiologic mechanisms that enhance our understanding of NASH-associated cardiomyopathy and the role of liver\u2013heart crosstalk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>An innovative, detailed, and mechanistic understanding of NASH-associated cardiomyopathy is relevant to public health and will be fundamental for the comprehensive care of these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000845","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T05:00:08Z","timestamp":1660021208000},"page":"295-299","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Mechanisms of nonalcoholic steatohepatitis-associated cardiomyopathy: key roles for liver\u2013heart crosstalk"],"prefix":"10.1097","volume":"33","author":[{"given":"Dolores B.","family":"Njoku","sequence":"first","affiliation":[{"name":"Division of Pediatric Anesthesiology, Department of Anesthesiology"},{"name":"Department of Pathology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.","family":"Schilling","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology"},{"name":"Cardiovascular Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian N.","family":"Finck","sequence":"additional","affiliation":[{"name":"Division of Geriatrics and Nutritional Sciences, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","article-title":"Gender and racial differences in nonalcoholic fatty liver disease","volume":"6","author":"Pan","year":"2014","journal-title":"World J Hepatol"},{"key":"R2-20250729","first-page":"134","article-title":"Nonalcoholic fatty liver disease (NAFLD) and risk of cardiac arrhythmias: a new aspect of the liver-heart axis","volume":"5","author":"Mantovani","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"e008910","DOI":"10.1161\/CIRCHEARTFAILURE.121.008910","article-title":"FGF21 (fibroblast growth factor 21) defines a potential cardiohepatic signaling circuit in end-stage heart failure","volume":"15","author":"Sommakia","year":"2022","journal-title":"Circ Heart Fail"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s10620-016-4040-6","article-title":"Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease","volume":"61","author":"Mantovani","year":"2016","journal-title":"Dig Dis Sci"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"12440","DOI":"10.1038\/s41598-020-69013-y","article-title":"Prevalence and staging of nonalcoholic fatty liver disease among patients with heart failure with preserved ejection fraction","volume":"10","author":"Miller","year":"2020","journal-title":"Sci Rep"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jacc.2021.11.007","article-title":"Risk of heart failure in patients with nonalcoholic fatty liver disease: JACC review topic of the week","volume":"79","author":"Mantovani","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1113\/EP087499","article-title":"Inflammation as a mediator of arterial ageing","volume":"104","author":"Trott","year":"2019","journal-title":"Exp Physiol"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"641.e14","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/FJC.0000000000000696","article-title":"NLRP3 inflammasome in cardioprotective signaling","volume":"74","author":"Zuurbier","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41598-022-06542-8","article-title":"Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy","volume":"12","author":"Kanno","year":"2022","journal-title":"Sci Rep"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2353\/ajpath.2008.070974","article-title":"Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling","volume":"173","author":"Bujak","year":"2008","journal-title":"Am J Pathol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.V75.6.1305.1305","article-title":"Interleukin-1 induces interleukin-6 production in peripheral blood monocytes","volume":"75","author":"Tosato","year":"1990","journal-title":"Blood"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: from physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J Hepatol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/s41423-021-00724-6","article-title":"Mitochondrial-triggered immune responses mechanistically connect drug-induced steatohepatitis and cardiomyopathy associated with nonalcoholic steatohepatitis","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13293-021-00368-1","article-title":"Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies","volume":"12","author":"Catal\u00e0-Senent","year":"2021","journal-title":"Biol Sex Differ"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in nonalcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog Lipid Res"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1073\/pnas.91.23.10878","article-title":"Beta-cell lipotoxicity in the pathogenesis of noninsulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships","volume":"91","author":"Lee","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J Lipid Res"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1742-4658.2010.07947.x","article-title":"Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans","volume":"278","author":"Wanders","year":"2011","journal-title":"FEBS J"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1073\/pnas.081627898","article-title":"Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension","volume":"98","author":"Holla","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1681\/ASN.2012070714","article-title":"Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase","volume":"24","author":"Wu","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ajh\/hpu300","article-title":"Aldosterone contributes to sympathoexcitation in renovascular hypertension","volume":"28","author":"Lincevicius","year":"2015","journal-title":"Am J Hypertens"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1440-1681.2010.05437.x","article-title":"The role of oxidative stress in renovascular hypertension","volume":"38","author":"Campos","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"H976","DOI":"10.1152\/ajpheart.00398.2009","article-title":"Myocardial lysyl oxidase regulation of cardiac remodeling in a murine model of diet-induced metabolic syndrome","volume":"297","author":"Zibadi","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1872-034X.2007.00156.x","article-title":"Influence of age and gender in Japanese patients with nonalcoholic steatohepatitis","volume":"37","author":"Yatsuji","year":"2007","journal-title":"Hepatol Res"},{"issue":"(Suppl 1)","key":"R33-20250729","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00535-010-0311-8","article-title":"Prevalence, gender, ethnic variations, and prognosis of NASH","volume":"46","author":"Hashimoto","year":"2011","journal-title":"J Gastroenterol"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","article-title":"Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"16","author":"Jaruvongvanich","year":"2017","journal-title":"Ann Hepatol"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/153537020422900204","article-title":"Sex differences in choline-deficient diet-induced steatohepatitis in mice","volume":"229","author":"Kashireddy","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"33649","DOI":"10.18632\/oncotarget.9259","article-title":"IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.4049\/jimmunol.1602186","article-title":"IL-33 signaling regulates innate IL-17A and IL-22 production via suppression of prostaglandin E(2) during lung fungal infection","volume":"199","author":"Garth","year":"2017","journal-title":"J Immunol"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"592865","DOI":"10.3389\/fimmu.2020.592865","article-title":"Corrigendum: blockade of IL-33R\/ST2 signaling attenuates toxoplasma gondii ileitis depending on IL-22 expression","volume":"11","author":"Ryffel","year":"2020","journal-title":"Front Immunol"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41423-018-0087-y","article-title":"In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity","volume":"16","author":"Cottagiri","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12079-018-0464-4","article-title":"A network map of IL-33 signaling pathway","volume":"12","author":"Pinto","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.118.11157","article-title":"IL-33 (interleukin 33)\/sST2 axis in hypertension and heart failure","volume":"72","author":"Ghali","year":"2018","journal-title":"Hypertension"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2017.04.022","article-title":"Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress","volume":"138","author":"Veeraveedu","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/cvr\/cvy166","article-title":"Conflicting vascular and metabolic impact of the IL-33\/sST2 axis","volume":"114","author":"Altara","year":"2018","journal-title":"Cardiovasc Res"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"722908","DOI":"10.3389\/fcvm.2021.722908","article-title":"FABP3 deficiency exacerbates metabolic derangement in cardiac hypertrophy and heart failure via PPAR\u03b1 pathway","volume":"8","author":"Zhuang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ijc.33777","article-title":"Fatty acid-binding protein 5 limits the generation of Foxp3(+) regulatory T cells through regulating plasmacytoid dendritic cell function in the tumor microenvironment","volume":"150","author":"Kobayashi","year":"2022","journal-title":"Int J Cancer"},{"key":"R48-20250729","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/hep.32072","article-title":"Nonalcoholic fatty liver disease and cardiac remodeling risk: pathophysiological mechanisms and clinical implications","volume":"74","author":"Zhou","year":"2021","journal-title":"Hepatology"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T22:03:49Z","timestamp":1753826629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000845","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}